CINCINNATI (WKRC) - New research from the Cleveland Clinic may explain why some people experience significant weight loss with GLP-1 medications, such as semaglutide injections marketed under brand ...
Hosted on MSN
Genetic variation may explain why some children exposed to diabetes in utero become obese and others don't
Children exposed to gestational diabetes in utero with a specific variation of a common gene are at a higher risk of becoming overweight or obese during childhood, according to a new study by ...
Why do GLP-1 drugs work better for some people than others? This large genetic study suggests inherited differences in drug-target genes may shape both weight-loss success and the risk of nausea and ...
Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from one‑size‑fits‑all treatment.
Woman's World on MSN
She lost 104 lbs. after finding her genetic weight-loss type—here's how
We know a one-size-fits-all diet isn't the answer for each individual body on the planet. But that can leave us overwhelmed ...
A new study suggests that the long-standing Mendelian view of genetics has some blind spots.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results